Hot Products

Chrysin
Catalog No: CFN98741

Chrysin, a naturally-occurring ligand for benzodiazepine receptors, with anticonvulsant , anti-inflammation, anti-cancer, hepatoprotective, and anti-oxidation properties. Chrysin induced apoptosis is mediated through caspase activation and Akt inactivation in U937 leukemia cells; it prevented the development of DN in HFD/STZ-induced type 2 diabetic rats through anti-inflammatory effects in the kidney by specifically targeting the TNF-α pathway.

Chrysin 6-C-arabinoside 8-C-glucoside
Catalog No: CFN92284

Chrysin-6-C-arabinosyl-8-C-glucoside and chrysin-6-C-glucosyl-8-C-arabinoside are α-glucosidase inhibitors, α-glucosidase inhibitors are widely used in the treatment of type 2 diabetes.

Chrysin 6-C-glucoside
Catalog No: CFN92360

Standard reference

Chrysin 6-C-glucoside 8-C-arabinoside
Catalog No: CFN92285

Chrysin-6-C-arabinosyl-8-C-glucoside and chrysin-6-C-glucosyl-8-C-arabinoside are α-glucosidase inhibitors, α-glucosidase inhibitors are widely used in the treatment of type 2 diabetes.

Chrysin 7-O-beta-D-glucopyranuronoside
Catalog No: CFN92279

Reference standards.

Chrysin 8-C-glucoside
Catalog No: CFN91992

Reference standards.

Chrysin dimethylether
Catalog No: CFN90896

Chrysin dimethylether shows moderate activity against Trypanosoma brucei, and the IC50s less than 5.0 microg/ml.

Chrysoeriol
Catalog No: CFN98785

Chrysoeriol has antioxidant, antiinflammatory, antitumor, antimicrobial, antiviral, and free radical scavenging activities, it also shows selective bronchodilator effect. Chrysoeriol can potently inhibit the induction of nitric oxide synthase by blocking activator protein 1 (AP-1) activation and its anti-inflammatory effects; it can potentially serve as a novel cardioprotective agent against doxorubicin (DOX)-induced cardiotoxicity without affecting the antitumor activity of DOX. Chrysoeriol may be used for the prevention and treatment of vascular diseases and during restenosis after coronary angioplasty, it can inhibit the downstream signal transduction pathways of platelet-derived growth factor (PDGF)-Rbeta, including ERK1/2, p38, and Akt phosphorylation.

Chrysoeriol 7-apiosylglucoside
Catalog No: CFN91104

Reference standards.

Chrysoeriol-7-O-glucoside
Catalog No: CFN93021

Chrysoeriol-7-O-glucoside can strongly inhibit the classical pathway of the complement system.Chrysoeriol-7-O-d-glucoside and luteolin-7-O-d-glucoside can inhibit palmitic acid uptake into small intestinal brush border membrane, apigenin-7-O-d-glucoside can inhibit alpha-amylase activity; they can enhance norepinephrine-induced lipolysis in fat cells.